Jennifer Whitty

Jennifer Whitty is a Professor at the University of East Anglia's Norwich Medical School, specializing in health economics. She holds affiliations with the Norwich Institute for Healthy Aging, Health Services and Primary Care, and the Respiratory and Airways Group. With a background in pharmacy, her research focuses on patient preferences, health outcomes valuation, and economic evaluation of healthcare technologies. She has secured over AU$27 million in research funding as Principal Investigator and collaborator, and contributes to health policy via roles such as membership of the National Immunoglobulin Governance Advisory Committee.

• Education: PhD (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992)

Her research interests include:

• Evaluation of patient and public preferences for healthcare services and outcomes
• Development of methods for measuring health-related quality of life
• Economic evaluation of telehealth and asset-based health initiatives
• Pharmacoeconomic analysis of pharmaceutical submissions to the Australian PBS

Recent projects include studies on cystic fibrosis treatment burden, value-based mental health care, and social return on investment of aging-friendly community programs. Her work contributes to UN Sustainable Development Goals related to health equity and quality education.

Grants and Funding: Over AU$9M as Chief Investigator, AU$10M as Associate Investigator, and AU$8M as consultant. Notable funders include the Australian Research Council and National Health and Medical Research Council.

Labs/Teams: Leads interdisciplinary teams in health economics, collaborates with Government Health Departments, and advises pharmaceutical companies on cost-effectiveness submissions.